Nuclera
Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. We make proteins accessible through eProtein DiscoveryTM. Through our technology, we accelerate breakthrough improvements in human health and empower life science researchers with easy access to target proteins.
Latest Content
Industry Insight
Advancing Protein Prototyping Through Rapid and Efficient Systems
In this interview, we learn more about Nuclera's eProtein Discovery™ system, cutting protein production to 48 hours, solving solubility challenges and accelerating R&D with a "fail fast, succeed faster" strategy.
Webinar
Accelerating Drug Target Identification and Characterization
On-Demand
This webinar highlights how a streamlined workflow combining recombinant protein expression and interaction analysis accelerates drug–target screening, scaling, and characterization, improving efficiency and enabling faster decisions in drug discover
Product News
Nuclera’s eProtein Discovery System Installed at Domainex To Streamline Protein Production Services
Nuclera, and Domainex, announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production services using the technology.
Product News
Nuclera Awarded £1.14M Innovate UK Funding for Development of eProtein Discovery
£790k FASST grant, in collaboration with DeepMirror, and £350k Engineering Biology grant awarded for platform development.
Product News
Nuclera eProtein Discovery System Installed at Leading Academic Institutes
Nuclera, announced it has successfully completed 11 installs of its eProtein Discovery™ system, including at leading academic institutes.
Advertisement
